CYP11A1 Polyclonal Antibody

CYP11A1 encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. Cholesterol side-chain cleavage enzyme mitochondrial localizes to the mitochondrial inner membrane and catalyzes the conversion of cholesterol to pregnenolone, the first and rate-limiting step in the synthesis of the steroid hormones. Two transcript variants encoding different isoforms have been found for this gene. The cellular location of the smaller isoform is unclear since it lacks the mitochondrial-targeting transit peptide.

Introducing the CYP11A1 Polyclonal Antibody, a highly specific and sensitive tool for the detection and quantification of CYP11A1 protein expression. This antibody has been rigorously tested and validated for use in a variety of applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The CYP11A1 Polyclonal Antibody is produced using state-of-the-art techniques and is designed to recognize multiple epitopes of the CYP11A1 protein. This ensures that the antibody is highly specific and able to detect even low levels of CYP11A1 expression.

This antibody is suitable for use in a wide range of research applications, including studies of steroidogenesis, endocrine disorders, and reproductive biology. It is also an essential tool for researchers investigating the role of CYP11A1 in various physiological and pathological processes.

In summary, the CYP11A1 Polyclonal Antibody is a reliable and versatile tool for the detection and quantification of CYP11A1 protein expression. Its high specificity and sensitivity make it an essential tool for researchers in a variety of fields.